MetLife Inc. reported strong second-quarter 2026 financial results, with adjusted earnings reaching USD 1.6 billion, representing a 15% increase from the prior-year period. Adjusted earnings per share rose significantly by 20% to USD 2.43, while the company achieved an adjusted return on equity of 17%, hitting the top end of its annual target range between 15% and 17%. These robust operating metrics provided a solid foundation for positive analyst sentiment surrounding the insurer's stock performance. Following the release of these results, Wells Fargo raised its price target for MetLife stock from USD 109.00 to USD 110.00 on October 12, 2026. This action contributes to a broader trend of positive analyst coverage, with Piper Sandler also maintaining an Overweight rating and a USD 110.00 target following its own upgrade in September. The average 12-month price target across analysts stands at USD 105.06, suggesting continued confidence in the company's valuation despite the stock trading around EUR 89.26. MetLife also announced a fourth-quarter 2026 dividend of USD 0.5925 per share on October 6, 2026, reinforcing its commitment to capital return to shareholders. The company is scheduled to publish its third-quarter 2026 results after market close on November 4, 2026, with an earnings call following on November 5, 2026. Investors will be watching to see if the demonstrated earnings growth and capital-return program can sustain the higher valuation case supported by recent analyst upgrades. MetLife Inc., trading under ticker MET on the NYSE, has a market capitalization of USD 63.4 billion as of October 14, 2026. The stock's 52-week range spans from USD 67.33 to USD 101.44, placing the current trading price within a reasonable band relative to its historical volatility. As a major player in the Financials and Insurance sectors, MetLife continues to balance growth initiatives with shareholder returns, supported by consistent operational performance.